Protea Fund - Sectoral Biotech Opportunities Fund Class IF Fonds
12,33
EUR
+0,02
EUR
+0,16
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,76% |
| Gilead Sciences Inc | US3755581036 | 7,81% |
| Amgen Inc | US0311621009 | 7,74% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 5,52% |
| Insmed Inc | US4576693075 | 4,21% |
| argenx SE ADR | US04016X1019 | 3,96% |
| United Therapeutics Corp | US91307C1027 | 2,76% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 2,69% |
| BridgeBio Pharma Inc | US10806X1028 | 2,55% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 2,42% |
| Sonstige | 50,57% |